Tyra Biosciences, Inc.
TYRA
$25.38
$0.361.42%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 353.94M | 383.47M | 256.00M | 274.92M | 296.27M |
| Total Receivables | 2.50M | 2.70M | 1.90M | 2.20M | 1.70M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.41M | 8.33M | 7.55M | 4.09M | 4.18M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 116.00K | 116.00K | -- | -- | -- |
| Total Current Assets | 366.97M | 394.61M | 265.45M | 281.22M | 302.16M |
|
|
|||||
| Total Current Assets | 366.97M | 394.61M | 265.45M | 281.22M | 302.16M |
| Net Property, Plant & Equipment | 6.48M | 6.66M | 6.89M | 7.05M | 7.24M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.91M | 10.77M | 10.27M | 13.59M | 12.11M |
| Total Assets | 383.36M | 412.04M | 282.61M | 301.85M | 321.50M |
|
|
|||||
| Total Accounts Payable | 2.33M | 3.64M | 1.18M | 1.99M | 2.25M |
| Total Accrued Expenses | 21.78M | 15.13M | 16.44M | 13.43M | 11.08M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 504.00K | 488.00K | 472.00K | 456.00K | 441.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 24.62M | 19.26M | 18.09M | 15.88M | 13.77M |
|
|
|||||
| Total Current Liabilities | 24.62M | 19.26M | 18.09M | 15.88M | 13.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.08M | 5.21M | 5.34M | 5.46M | 5.58M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 29.70M | 24.47M | 23.43M | 21.34M | 19.35M |
|
|
|||||
| Common Stock & APIC | 810.37M | 798.03M | 630.04M | 617.49M | 609.27M |
| Retained Earnings | -456.12M | -410.56M | -371.26M | -337.42M | -307.56M |
| Treasury Stock & Other | -580.00K | 107.00K | 393.00K | 442.00K | 436.00K |
| Total Common Equity | 353.66M | 387.58M | 259.18M | 280.51M | 302.15M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 353.66M | 387.58M | 259.18M | 280.51M | 302.15M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 353.66M | 387.58M | 259.18M | 280.51M | 302.15M |
|
|
|||||